Literature DB >> 33214329

Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.

Amandeep K Sahota1,2, Warren L Shapiro1,3,4,2, Kimberly P Newton3,4, Steven T Kim1, Joanie Chung1, Jeffrey B Schwimmer5,4.   

Abstract

BACKGROUND AND OBJECTIVES: In 2007, the American Academy of Pediatrics recommended that children with obesity should be screened for nonalcoholic fatty liver disease (NAFLD). Population epidemiology reveals that NAFLD is common in children; however, little is known about rates of clinical diagnosis. In this study, we aim to determine screening practices, annual incidence, and clinical characteristics of NAFLD in children within an integrated community health system.
METHODS: Using electronic health records, we identified patients newly diagnosed (aged 5-18) with NAFLD on the basis of diagnostic codes from the 9th and 10th revisions of the International Classification of Diseases. We calculated screening rates and annual incidence rates of NAFLD from January 1, 2009, to December 31, 2018.
RESULTS: In this study, we evaluated 7 884 844 patient-years. Screening was performed in 54.0% of children with obesity and 24.0% of children with overweight. The results revealed 36 658 children aged 9 to 18 with overweight or obesity and alanine aminotransferase >30 U/L. Of these children, 12.3% received further workup for NAFLD. The incidence of an NAFLD diagnosis significantly increased over time, with 36.0 per 100 000 in 2009 and 58.2 per 100 000 in 2018 (P < .0001).
CONCLUSIONS: Our study of a large integrated health care system in southern California revealed that the incidence of NAFLD in children is increasing, although many children may remain undiagnosed.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 33214329      PMCID: PMC7706110          DOI: 10.1542/peds.2020-0771

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

2.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

3.  Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.

Authors:  Elizabeth L Yu; Shahrokh Golshan; Kathryn E Harlow; Jorge E Angeles; Janis Durelle; Nidhi P Goyal; Kimberly P Newton; Mary Catherine Sawh; Jonathan Hooker; Ethan Z Sy; Michael S Middleton; Claude B Sirlin; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2018-12-14       Impact factor: 4.406

4.  Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists.

Authors:  Matthew Ryan Riley; Nathan Michael Bass; Philip Rosenthal; Raphael B Merriman
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

5.  Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United States.

Authors:  Warren L Shapiro; Elizabeth L Yu; Jennifer C Arin; Karen F Murray; Sabina Ali; Nirav K Desai; Stavra A Xanthakos; Henry C Lin; Naim Alkhouri; Reham Abdou; Stephanie H Abrams; Megan W Butler; Sarah A Faasse; Lynette A Gillis; Timothy A Hadley; Ajay K Jain; Marianne Kavan; Kattayoun Kordy; Peter Lee; Jennifer Panganiban; John F Pohl; Carol Potter; Bryan Rudolph; Shikha S Sundaram; Shivali Joshi; James A Proudfoot; Nidhi P Goyal; Kathryn E Harlow; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-02       Impact factor: 2.839

6.  Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

Authors:  Jean A Welsh; Saul Karpen; Miriam B Vos
Journal:  J Pediatr       Date:  2012-10-17       Impact factor: 4.406

Review 7.  Paediatric fatty liver disease (PeFLD): All is not NAFLD - Pathophysiological insights and approach to management.

Authors:  Robert Hegarty; Maesha Deheragoda; Emer Fitzpatrick; Anil Dhawan
Journal:  J Hepatol       Date:  2018-02-20       Impact factor: 25.083

8.  Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report.

Authors:  Sarah E Barlow
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

9.  Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Anne Zepeda; Kimberly P Newton; Stavra A Xanthakos; Cynthia Behling; Erin K Hallinan; Michele Donithan; James Tonascia
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

Review 10.  The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.

Authors:  Emma L Anderson; Laura D Howe; Hayley E Jones; Julian P T Higgins; Debbie A Lawlor; Abigail Fraser
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

View more
  16 in total

1.  Nonalcoholic Fatty Liver Disease in Children.

Authors:  Katherine F Sweeny; Christine K Lee
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-12

2.  Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.

Authors:  Samer Gawrieh; Kathryn E Harlow; Francis Pike; Katherine P Yates; Laura A Wilson; Oscar W Cummings; William M Rosenberg; Naga Chalasani; Jean P Molleston
Journal:  J Pediatr       Date:  2021-08-13       Impact factor: 4.406

Review 3.  Recent advances in the epidemiology of nonalcoholic fatty liver disease in children.

Authors:  Warren L Shapiro; Sheila L Noon; Jeffrey B Schwimmer
Journal:  Pediatr Obes       Date:  2021-09-09       Impact factor: 4.000

4.  Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.

Authors:  Victoria Lee-Kim; Rachael Morkem; David Barber; Jennifer A Flemming; Mohit Kehar
Journal:  Paediatr Child Health       Date:  2021-08-27       Impact factor: 2.600

5.  Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children.

Authors:  Cynthia A Moylan; Alisha M Mavis; Dereje Jima; Rachel Maguire; Mustafa Bashir; Jeongeun Hyun; Melanie N Cabezas; Alice Parish; Donna Niedzwiecki; Anna Mae Diehl; Susan K Murphy; Manal F Abdelmalek; Cathrine Hoyo
Journal:  Epigenetics       Date:  2022-02-21       Impact factor: 4.861

6.  Childhood nutrient intakes are differentially associated with hepatic and abdominal fats in adolescence: The EPOCH study.

Authors:  Catherine C Cohen; Wei Perng; Traci A Bekelman; Brandy M Ringham; Ann Scherzinger; Kartik Shankar; Dana Dabelea
Journal:  Obesity (Silver Spring)       Date:  2022-02       Impact factor: 9.298

7.  Exposure to maternal fuels during pregnancy and offspring hepatic fat in early childhood: The healthy start study.

Authors:  Catherine C Cohen; Ellen C Francis; Wei Perng; Katherine A Sauder; Ann Scherzinger; Shikha S Sundaram; Kartik Shankar; Dana Dabelea
Journal:  Pediatr Obes       Date:  2022-02-05       Impact factor: 3.910

8.  The Prevalence of Elevated Alanine Aminotransferase Levels Meeting Clinical Action Thresholds in Children with Obesity in Primary Care Practice.

Authors:  Stephanie J Wu; Jeanne A Darbinian; Jeffrey B Schwimmer; Elizabeth L Yu; Nirmala D Ramalingam; Louise C Greenspan; Joan C Lo
Journal:  J Pediatr       Date:  2021-09-23       Impact factor: 4.406

Review 9.  COVID-19 and pediatric fatty liver disease: Is there interplay?

Authors:  Anna Di Sessa; Francesca Lanzaro; Sarah Zarrilli; Vittorio Picone; Stefano Guarino; Emanuele Miraglia Del Giudice; Pierluigi Marzuillo
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

10.  Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progression.

Authors:  Nita H Salzman; Jeffrey B Schwimmer
Journal:  Curr Opin Endocr Metab Res       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.